Valneva SE Under Investigation
Bragar Eagel & Squire, P.C. is actively investigating Valneva SE on behalf of its stockholders. The law firm aims to uncover any potential violations of federal securities laws or unlawful business practices committed by Valneva.
Importance of Investor Awareness
If you are an investor who has suffered losses due to stock transactions in Valneva, it is crucial to be informed about your legal rights. Contacting experienced professionals can elucidate your options for recourse.
Recent Events Triggering the Investigation
On February 25, there was notable concern when the CDC announced investigations into health issues potentially linked to Valneva's chikungunya virus vaccine, IXCHIQ. This announcement raised alarms among investors. Following the CDC's communication, Valneva's American Depositary Receipt (ADR) plummeted significantly, reflecting a loss of investor confidence.
Impact of Safety Announcements
The CDC's statement about five hospitalizations among older adults after vaccination triggered a $1.06 decline per ADR for Valneva, representing a 13.57% decrease. Investors reacted sharply to this news, prompting questions regarding the safety and reliability of the vaccine.
FDA's Marketing Application Suspension
The situation escalated when the FDA declared the suspension of IXCHIQ's marketing application due to safety concerns on August 22. This announcement led to a further decrease in the company's ADR price, which dropped by $2.21 or 18.99%. The cumulative effects of these revelations warrant scrutiny and hence, the active investigation by Bragar Eagel & Squire.
How to Engage with Legal Professionals
Stockholders who believe they might have been adversely affected by recent developments are encouraged to engage with Bragar Eagel & Squire. Investors can discuss their circumstances and determine safer paths forward through legal acknowledgment. The firm wants to help stockholders understand their positions regarding these claims.
Take Action Now
If you are an investor in Valneva and are seeking to understand more about your legal rights related to your shares, it's advisable to reach out directly. Legal experts are available to provide assistance and help illuminate your available options.
Ongoing Commitment to Investors
Bragar Eagel & Squire emphasizes its dedication to defending the rights of individual and institutional investors across the United States. With a robust understanding of investor needs and extensive experience, the firm remains at the forefront of holding corporations accountable for their actions.
Frequently Asked Questions
What is the investigation about?
The investigation focuses on potential violations of federal securities laws by Valneva SE and other unlawful practices that may have negatively impacted investors.
How can I participate in the investigation?
Investors are encouraged to contact Bragar Eagel & Squire to discuss their losses and potential claims against Valneva SE.
What should I do if I suffered losses?
If you’ve incurred losses due to your investments in Valneva, it's important to seek legal advice to understand your rights and options.
Where can I find more information about Bragar Eagel & Squire?
More details about the firm can be found on their website, which provides comprehensive information on their services and expertise.
Who can I contact for legal support?
Bragar Eagel & Squire can be reached directly at (212) 355-4648 for discussions regarding legal support or inquiries related to Valneva SE.